• Explore /
  • Poster
  • / Tumor cell budding as a prognostic and potentially therapeutically targetable biomarker in head and neck cancer.

Tumor cell budding as a prognostic and potentially therapeutically targetable biomarker in head and neck cancer.

Abstract Poster

Authors

null

Jan Budczies

Institute of Pathology, University of Heidelberg, Heidelberg, Germany

Jan Budczies , Iordanis Ourailidis , Susanne Beck , Wilko Weichert , Peter Schirmacher , Albrecht Stenzinger , Fabian Stögbauer , Melanie Boxberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Biologic Correlates

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6053)

DOI

10.1200/JCO.2022.40.16_suppl.6053

Abstract #

6053

Poster Bd #

45

Abstract Disclosures

Similar Posters

First Author: Benny Johnson

First Author: Bailey Fabiny Garb

First Author: Jerome Fayette

First Author: Nai-Jung Chiang